TY - CHAP
T1 - Network-based analysis for uncovering mechanisms underlying Alzheimer's disease
AU - Kikuchi, Masataka
AU - Ogishima, Soichi
AU - Mizuno, Satoshi
AU - Miyashita, Akinori
AU - Kuwano, Ryozo
AU - Nakaya, Jun
AU - Tanaka, Hiroshi
N1 - Publisher Copyright:
© Springer Science+Business Media New York 2015. All right reserved.
PY - 2015/8/2
Y1 - 2015/8/2
N2 - Alzheimer's disease (AD) is known to be a multifactorial neurodegenerative disorder, and is one of the main causes of dementia in the elderly. Many studies have demonstrated molecules involved in the pathogenesis of AD, however its underlying mechanisms remain obscure. It may be simplistic to try to explain the disease based on the role of a few genes only. Accumulating new, huge amount of information from e.g. genome, proteome and interactome datasets and new knowledge, we are now able to clarify and characterize diseases essentially as a result of dysfunction of molecular networks. Recent studies have indicated that relevant genes affected in human diseases concentrate in a part of the network, often called as "disease module." In the case of AD, some disease-associated pathways seem different, but some of them are clearly disease-related and coherent. This suggests the existence of a common pathway that negatively drives from healthy state to disease state (i.e., the disease module(s)). Additionally, such disease modules should dynamically change through AD progression. Thus, network-level approaches are indispensable to address unknown mechanisms of AD. In this chapter, we introduce network strategies using gene co-expression and protein interaction networks.
AB - Alzheimer's disease (AD) is known to be a multifactorial neurodegenerative disorder, and is one of the main causes of dementia in the elderly. Many studies have demonstrated molecules involved in the pathogenesis of AD, however its underlying mechanisms remain obscure. It may be simplistic to try to explain the disease based on the role of a few genes only. Accumulating new, huge amount of information from e.g. genome, proteome and interactome datasets and new knowledge, we are now able to clarify and characterize diseases essentially as a result of dysfunction of molecular networks. Recent studies have indicated that relevant genes affected in human diseases concentrate in a part of the network, often called as "disease module." In the case of AD, some disease-associated pathways seem different, but some of them are clearly disease-related and coherent. This suggests the existence of a common pathway that negatively drives from healthy state to disease state (i.e., the disease module(s)). Additionally, such disease modules should dynamically change through AD progression. Thus, network-level approaches are indispensable to address unknown mechanisms of AD. In this chapter, we introduce network strategies using gene co-expression and protein interaction networks.
KW - Alzheimer's disease
KW - Disease module
KW - Gene co-expression network
KW - Gene expression profile
KW - Network dysfunction
KW - Network perturbation
KW - Protein interaction network
KW - Systems biology
UR - http://www.scopus.com/inward/record.url?scp=84958605455&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84958605455&partnerID=8YFLogxK
U2 - 10.1007/978-1-4939-2627-5_29
DO - 10.1007/978-1-4939-2627-5_29
M3 - Chapter
C2 - 26235086
AN - SCOPUS:84958605455
SN - 9781493926268
SP - 479
EP - 491
BT - Systems Biology of Alzheimer's Disease
PB - Springer New York
ER -